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Nicotinic α7 acetylcholine receptor-mediated currents are not 
modulated by the tryptophan metabolite kynurenic acid in adult 
hippocampal interneurons
Peter Dobelis1*, Andrew L. Varnell1, Kevin J. Staley2, & Donald C. Cooper1
The  tryptophan  metabolite,  kynurenic  acid  (KYNA),  is  classically  known  to  be  an  antagonist  of  ionotropic  glutamate  receptors.  
Within   the   last   decade   several   reports   have   been   published   suggesting   that   KYNA   also   blocks   nicotinic   acetylcholine  
receptors  (nAChRs)  containing  the  α7  subunit  (α7*).  Most  of  these  reports  involve  either  indirect  measurements  of  KYNA  
effects  on  α7  nAChR   function,  or  are   reports  of  KYNA  effects   in  complicated   in  vivo  systems.  However,  a   recent   report  
investigating  KYNA  interactions  with  α7  nAChRs  failed  to  detect  an  interaction  using  direct  measurements  of  α7  nAChRs  
function.  Further,  it  showed  that  a  KYNA  blockade  of  α7  nAChR  stimulated  GABA  release  (an  indirect  measure  of  α7  nAChR  
function)  was  not  due  to  KYNA  blockade  of  the  α7  nAChRs.  The  current  study  measured  the  direct  effects  of  KYNA  on  α7-­
containing  nAChRs  expressed  on  interneurons  in  the  hilar  and  CA1  stratum  radiatum  regions  of  the  mouse  hippocampus  
and  on  interneurons  in  the  CA1  region  of  the  rat  hippocampus.  Here  we  show  that  KYNA  does  not  block  α7*  nACHRs  using  
direct  patch-­clamp  recording  of  α7  currents  in  adult  brain  slices.
Kynurenic acid (KYNA) is produced by the metabolism of 
tryptophan via the kynurenine pathway1,3. Classically, KYNA 
is known for its antagonist actions at ionotropic glutamate 
receptors, showing the greatest a"nity for NMDA-mediated 
glutamatergic responses2. Altered levels of KYNA have been 
associated with several disease states; increased KYNA levels 
are seen with Alzheimer’s disease, Down’s syndrome, and 
schizophrenia while decreased KYNA levels are associated 
with end stage Parkinson’s and Huntington’s disease3. 
Additionally, animal studies indicate that increased brain 
levels of KYNA are neuroprotective and anti convulsant, 
while decreased KYNA levels are associated with an increased 
vulnerability to excitotoxic damage4.
 Another action attributed to KYNA is the antagonism 
of α7 subunit-containing (α7*) nicotinic acetylcholine 
receptors (nAChRs). Several reports from Albuquerque and 
colleagues present data demonstrating that KYNA also blocks 
the activation of α7* nAChRs4. However, a recent report from 
Mok and colleagues examining the e#ects of KYNA on several 
di#erent ligand gated ion channels revealed that KYNA had 
no e#ect on α7* nAChRs6.  Here we present the results of our 
investigation of KYNA e#ects on α7* nAChRs  expressed on 
interneurons in the hilar and CA1 stratum radiatum (SR) 
regions of the mouse hippocampus, as well as α7* nAChRs 
expressed on interneurons the rat CA1 SR.
RESULTS
Kynurenic acid e!ects on α7* nAChRs expressed on 
mouse hilar interneurons
 $e results obtained form choline-induced 
α7* currents in hilar interneurons are shown in Fig 1. 
We initially examined the prevalence of α7* currents in 
hilar interneurons. Out of the 23 neurons studied, 20 
displayed choline-induced and methyllycaconitine (MLA) 
sensitive whole cell currents characteristic of α7* nAChRs. 
Furthermore, in experiments using α7* null mutant mice, 
no choline-induced currents were detected (Fig 1a and 1b). 
Next, we examined the e#ects of KYNA on the choline-
induced α7* currents. In these experiments, stable baseline 
Fig 1: a. Representative traces for the characterization of α7* currents in mouse 
hilar interneurons. $e le% most trace shows the control response to pressure 
applied choline. $e next two traces show the response to choline in the pres-
ence of MLA (10 nM) and a%er 30 min washout, respectively. $e last trace 
shows the lack of response to choline in α7 null mutant mice. b. Methylly-
caconitine (MLA) completely blocked the choline response (p = 0.0003 con-
trol vs MLA, n = 8), the MLA e#ect was reversed partially a%er a washout 
(p = 0.035 washout vs. MLA, p = 0.005 washout vs control, n = 8), and the 
choline response for the α7* null mutant mice di#ered signi&cantly from wild 
type (p = 0.0003, n = 8). c. Representative traces for the e"ect of the bath ap-
plied KYNA on choline-evoked α7* currents. $e top trace shows the control 
response to pressure applied choline; note the overriding glutamatergic spon-
taneous EPSCs. $e middle trace shows the choline response a%er a 30 min 
exposure to 1 mM KYNA; note the absence of the spontaneous EPSCs. $e 
bottom trace shows the response to choline a%er a 20 min. washout of KYNA; 
note the reappearance of the spontaneous EPSCs. d. KYNA failed to produce 
any reduction in the choline response (p = 0.97, n = 20).
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α7* currents were obtained, followed by bath application 
of KYNA (1 mM) for 30 min. Choline-evoked α7* currents 
were  then measured a%er a 20 min washout of KYNA (Fig 
1c). $e top trace shows a choline-evoked α7* response with 
overriding spontaneous glutamatergic-mediated EPSCs. $e 
middle trace shows the choline-evoked α7* response a%er a 
30 min bath application of 1 mM KYNA. $e absence of the 
EPSCs  indicates the presence of KYNA. $e bottom trace 
shows the choline-evoked response a%er a 20 min washout 
of KYNA. Spontaneous EPSCs returned, indicating the 
removal of KYNA from the slice (Fig 1d). Out of the 20 hilar 
interneurons, KYNA failed to have any signi&cant e#ect on 
the choline-evoked α7*-mediated currents. 
KYNA e!ects on α7* nAChRs expressed on mouse and rat 
CA1 SR interneurons
To determine whether there are regional and/or species 
di#erences in α7* nAChR sensitivity to KYNA, we tested 
the ability of KYNA to block α7* nAChR currents in 
interneurons in the CA1 SR region in both mice and rats. 
$e representative traces for choline-evoked α7* currents 
in the mouse CA1 SR appear simular to the KYNA treated 
cells, indicating no change (Fig 2a). $e top trace shows the 
control response to pressure applied choline (10 mM) and the 
bottom trace shows the choline response in the presence of 1 
mM KYNA for 30 min. KYNA failed to signi&cantly reduce 
choline-evoked α7* currents in the &ve CA1 SR interneurons 
we tested (Fig 2b). Representative  traces from α7* currents 
a%er the pressure applied ACh (1 mM) and KYNA exposure 
in rat CA1 SR interneurons also showed no change (Fig 2c). 
$e top trace shows the control response, the middle trace 
shows the response in the presence of 1 mM KYNA, and the 
bottom trace shows the response in the presence of the α7-
selective antagonist MLA (10 mM). Exposure to a 20 min 
KYNA bath failed to inhibit α7* currents, while subsequent 
exposure to MLA produced a greater than 80% blockade of 
α7* currents (Fig 2d).
DISCUSSION
$ese results clearly indicate that KYNA has no e#ect on α7* 
nAChRs in the hilar and CA1 regions of adult mouse and rat 
hippocampal interneurons. $ese results are consistent with 
those reported by Mok and colleagues6.  Others have concluded 
that KYNA does interact with the  α7* nAChRs using indirect 
measures of  α7* function4.  KYNA has recently been shown 
to activate the orphan G-protein receptor GPR-351. GPR-35 
is coupled to the Gi-o pathway and is expressed throughout the 
rodent brain1. $is, in addition to the interactions that KYNA 
has with other ligand-gated receptors4 suggests that prior 
direct α7* mediated physiological e#ects attributed to KYNA 
must be made with caution.  Further studies are needed to 
resolve the apparent e#ects of KYNA on α7* nAChRs.  Until 
then the most direct evidence indicates no role for KYNA on 
α7* nAChR function.
METHODS
Slice preparation and recordings
Hippocampal slices were prepared as described by Proctor 
and colleagues7. Whole-cell recordings were made using a 
standard potassium gluconate based internal solution and 
a standard ACSF solution. KYNA and MLA were both bath 
applied to the tissue slices. Both choline and acetylcholine  
were pressure applied to the slices using established protocols. 
Expanded methods and recordings can be found at
http://www.neuro-cloud.net/nature-precedings/dobelis/ .
Fig 2. a. Representative traces for choline-evoked α7* currents in mouse 
stratum radiatum (SR) interneurons. $e top trace is the control response 
to pressure applied choline (10 mM, 50 ms). $e bottom trace shows the 
choline response a%er a 30 min. bath exposure to 1 mM KYNA. b. KYNA 
failed to reduce the choline response (p = 0.44, n = 5). c. Representative traces 
for pressure applied ACh-evoked α7* currents in rat CA1 SR interneurons. $e 
top trace shows the control response to 1 mM ACh. $e middle trace shows 
the ACh respose a%er the 30 min. bath exposure to 1 mM KYNA. the bottom 
trace shows the ACh response a%er a 20 min. bath exposure to 10 nM MLA. 
d. $e last &ve traces were averaged for each condition: control, KYNA, and 
MLA. KYNA failed to block the ACh-induced α7* currents (p = 0.71) while 
MLA signi&cantly blocked the response (p = 0.0001, n = 5).
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